Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France – the POP study

Published:2023-11 Issue:1 Volume:11 Page:
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Villani A. P.¹,Quiles Tsimaratos N.²,Crochard A.³,Gherardi A.³,Panes A.⁴,Schmidt A.⁴,Hueber Kollen M.³,Borget I.⁵

Affiliation:

1. Department of Dermatology, Edouard Herriot Hospital Center, Lyon, France

2. Department of Dermatology, Saint-Joseph Hospital Center, Marseille, France

3. UCB Pharma S.A, Colombes, France

4. HEVA, Lyon, France

5. Biostatistics and Epidemiology office, Gustave Roussy, Paris-Saclay University, Villejuif, France

Funder

UCB Pharma SA

Publisher

MDPI AG

Subject

Health Informatics,Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2023.2270293

Reference28 articles.

1. A systematic review of worldwide epidemiology of psoriasis

2. Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real‐world analysis of the French national health insurance database

3. Sex‐ and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study

4. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study

5. Disease burden and quality of life in patients with moderate‐to‐severe psoriasis stratified according to previous systemic treatment exposure